Related Experiment Video

Updated: Aug 8, 2026

DNA Vector-based RNA Interference to Study Gene Function in Cancer
13:10

DNA Vector-based RNA Interference to Study Gene Function in Cancer

Published on: June 4, 2012

Therapeutic short hairpin RNA expression in the liver: viral targets and vectors

D Grimm1, M A Kay

  • 1Department of Pediatrics, School of Medicine, Stanford University, Stanford, CA 94305, USA.

Gene Therapy
|February 3, 2006
PubMed

Insights

RNA interference offers a promising new antiviral therapy for hepatitis C virus (HCV) infection. This approach is timely due to new animal models and advancements in liver-specific short hairpin RNA technology.

Area of Science:

  • Hepatology
  • Virology
  • Gene Therapy

Background:

  • Over 500 million people globally are infected with human hepatitis viruses, facing risks of severe liver disease.
  • Current treatments for chronic hepatitis infections, especially hepatitis C virus (HCV), are limited and often ineffective.
  • Vaccines exist for hepatitis A and B, but therapeutic options for chronic cases remain a significant unmet need.

Purpose of the Study:

  • To review the current developments in RNA interference (RNAi) as a potential antiviral therapy for hepatitis C virus (HCV).
  • To discuss the feasibility and future directions for translating RNAi-based therapies into clinical practice for HCV.

Main Methods:

  • Critical review of recent advancements in RNA interference technology for antiviral applications.
  • Analysis of emerging in vivo animal models for studying HCV infection.
  • Evaluation of progress in liver-specific expression of short hairpin RNAs (shRNAs).

Main Results:

  • RNA interference (RNAi) is emerging as a potent strategy for developing novel antiviral therapies.
  • The availability of in vivo animal models for HCV is crucial for preclinical development.
  • Significant progress has been made in technologies enabling targeted, liver-specific delivery of therapeutic RNA molecules.

Conclusions:

  • RNA interference holds considerable promise for treating chronic hepatitis C virus infections.
  • Further research and development are needed to advance RNAi-based therapies from preclinical studies to clinical application.
  • The convergence of improved animal models and gene silencing technologies positions RNAi as a key future therapeutic avenue for HCV.

More Related Videos

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy12:03

Evaluation of the Efficacy And Toxicity of RNAs Targeting HIV-1 Production for Use in Gene or Drug Therapy

Published on: September 5, 2016

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA04:29

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA

Published on: November 1, 2024

Related Concept Videos

RNA Interference01:23

RNA Interference

RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the ATP-dependent...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...